Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001209191-20-052656

EVP, Research & CSO sold 3,510 shares at $38.00 ($133,380)

  • EVP, Research & CSO acquired 3,510 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Virgin Herbert · EVP, Research & CSO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2020-09-29 Exercise or conversion : show line 1 in the form +3,510 $1.53 $5,370 27,210 D
2020-09-29 Sale : show line 2 in the form −3,510 $38.00 $133,380 23,700 D
Open-market sales · 3,510 sh · avg $38.00 · $133,380

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-09-29 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −3,510 459,875 D
Loading xslF345X03/doc4.xml…